Glucagon-like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk: Balancing Reassurance and Vigilance
12 Aug 2026, 4 p.m.
Publication date: Available online 11 August 2026Source: PancreatologyAuthor(s): Jianing Li, ...
24th Feb 2020
...exploring novel technological approaches for the early detection of pancreatic cancer. read more..
10th Feb 2020
Pancreatic ductal adenocarcinoma (PDAC) is predicted to be the second most common cause of death within the next 10 years... read more..